Hypermarcas (OTCMKTS:HYPMY) Sees Unusually-High Trading Volume – Here’s Why

Hypermarcas (OTCMKTS:HYPMY) shares saw strong trading volume on Friday . 118,047 shares changed hands during mid-day trading, an increase of 361% from the previous session’s volume of 25,629 shares.The stock last traded at $4.12 and had previously closed at $4.04.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Hypermarcas currently has a consensus rating of “Buy”.

Hypermarcas Trading Up 2.2%

The business has a 50 day moving average of $4.50 and a two-hundred day moving average of $4.46. The firm has a market capitalization of $2.91 billion, a price-to-earnings ratio of 8.60 and a beta of 0.70. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. The firm had revenue of $383.13 million during the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. Equities analysts predict that Hypermarcas will post 0.53 EPS for the current year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.